Europe Anti-Snoring Device Market: Growth, Trends & Forecasts (2025-2033)

Sleep, once considered a passive necessity, is now widely recognized as a cornerstone of long-term health, and productivity. Across Europe, this shift in mindset is transforming how people approach sleep-related disorders—particularly snoring and obstructive sleep apnea (OSA). What was once dismissed as a minor inconvenience or a household nuisance is increasingly understood as a medical concern with serious implications for cardiovascular, metabolic, and cognitive health.

Against this backdrop, the Europe anti-snoring device market is experiencing significant growth. Market analysis indicates the market is expected to reach US$919.37 million by 2033, up from US$485.18 million in 2024, representing a compound annual growth rate (CAGR) of 7.36% from 2025 to 2033. This growth reflects not only rising awareness of sleep disorders but also the impact of demographic changes, lifestyle shifts, and continuous technological innovation in non-invasive sleep therapy solutions.

Anti-snoring devices—ranging from simple nasal dilators to more advanced oral appliances and Expiratory Positive Airway Pressure (EPAP) devices—are increasingly viewed as accessible, cost-effective alternatives or complements to traditional treatments such as Continuous Positive Airway Pressure (CPAP) machines. As healthcare systems across Europe place greater emphasis on preventive care and quality of life, demand for these devices is set to accelerate further.

Europe Anti-Snoring Device Market Overview

The European anti-snoring device market is being shaped by a combination of medical necessity, consumer awareness, and product innovation. A significant portion of the adult population in Europe experiences habitual snoring, and a substantial share of these individuals are either undiagnosed or undertreated for conditions such as obstructive sleep apnea. OSA, in particular, is closely linked with obesity, aging, and lifestyle factors—trends that are becoming more pronounced across the region.

Healthcare providers are increasingly encouraging early intervention, as untreated sleep disorders are associated with higher risks of hypertension, heart disease, stroke, diabetes, and reduced cognitive performance. This has fueled interest in non-invasive, easy-to-use devices that can be adopted at home without the need for complex clinical setups.

Technological progress is playing a central role in reshaping this market. Manufacturers are introducing smart anti-snoring devices with features such as sleep tracking, vibration alerts, and mobile app connectivity. These innovations allow users to monitor their sleep patterns, adjust device settings, and improve long-term compliance. Custom-fitted oral appliances, especially mandibular advancement devices (MADs) and tongue-stabilizing devices (TSDs), are also gaining traction due to their improved comfort and effectiveness compared to earlier, one-size-fits-all solutions.

The growth of e-commerce and telemedicine in Europe has significantly improved access to these products. Consumers can now research, compare, and purchase both over-the-counter and prescription-based solutions online, often supported by virtual consultations with healthcare professionals. This digital shift is helping to expand the market beyond traditional hospital and clinic settings into everyday homecare environments.

Key Factors Driving Market Growth

Aging Population and Lifestyle Changes

Europe’s aging population is a significant driver of the anti-snoring device market. As people age, physiological changes such as reduced muscle tone in the upper airway and increased fat deposition around the neck make snoring and sleep apnea more common. Simultaneously, lifestyle-related risk factors—including sedentary behavior, poor dietary habits, rising obesity rates, stress, and alcohol consumption—are affecting not only older adults but also younger demographics.

These combined trends are expanding the pool of individuals who experience chronic snoring or are at risk of OSA. For many of these patients, non-invasive anti-snoring devices represent an attractive first step before considering more complex or intrusive treatments. The growing focus on maintaining quality of life in later years is also encouraging older adults to seek solutions that improve sleep quality, daytime energy levels, and overall well-being.

Technological Advancements and Product Innovation

Innovation is a major catalyst for market expansion. Today’s devices are no longer limited to basic mechanical solutions. Instead, they increasingly incorporate digital health features, such as sensors that detect snoring, smart algorithms that analyze sleep patterns, and mobile applications that provide personalized feedback and recommendations.

Custom-fitted oral appliances, particularly mandibular advancement devices, are benefiting from advances in dental scanning and 3D printing technologies. These improvements allow for better fit, greater comfort, and higher treatment effectiveness—key factors in improving patient adherence. Positional therapy devices, including wearable bands and smart posture-correction tools, are also gaining popularity among users who primarily snore when sleeping on their backs.

Growing Awareness and Sleep Health Education

Across Europe, sleep health is steadily moving up the public health agenda. Medical professionals, public health agencies, and non-profit organizations are investing more resources into educating people about the consequences of poor sleep and untreated sleep disorders. Campaigns highlighting the links between snoring, sleep apnea, and serious conditions such as cardiovascular disease and cognitive decline are changing public perceptions.

This growing awareness is reducing the stigma around sleep-related problems and encouraging more individuals to seek diagnosis and treatment. Demand for accessible and user-friendly anti-snoring devices is rising. Consumers are no longer viewing these products as mere lifestyle accessories, but as legitimate health interventions that can improve both short-term comfort and long-term health outcomes.

Challenges in the European Market

Lack of Awareness in Certain Regions

While awareness of sleep disorders is relatively high in Western and Northern Europe, parts of Eastern and Southern Europe still lag behind. In these regions, limited access to sleep clinics, fewer public health campaigns, and cultural attitudes that downplay snoring as a medical issue contribute to widespread underdiagnosis.

Low Patient Compliance and Discomfort

Patient compliance remains a persistent challenge. Although many devices are clinically effective, users often discontinue them due to discomfort, dry mouth, jaw pain, or difficulty adjusting to sleeping with a device in place. Tongue-retaining devices and some mandibular advancement devices, in particular, can cause irritation or soreness during the initial adaptation period.

Regional Market Overview

Western and Northern Europe currently dominate the market due to higher awareness levels, better healthcare infrastructure, and stronger adoption of preventive health measures. Eastern and Southern Europe, while offering significant long-term potential, currently trail behind due to underdiagnosis, lower awareness, and limited access to specialized sleep care.

The United Kingdom is experiencing rapid market expansion as more people recognize snoring as a medical issue. Germany benefits from a robust healthcare system and high awareness of sleep disorders, with oral appliances being a popular treatment option. In Italy and France, the market is growing steadily as awareness increases and consumers seek non-invasive alternatives.

Market Segmentation

The market is segmented by product type, including oral appliances, nasal devices, tongue-stabilizing devices, chin straps, position control devices, and EPAP therapy devices. Distribution channels include retail pharmacies and online stores. End users are categorized as homecare and other. Key companies in the market include Royal Philips NV, ResMed, Inc., SomnoMed Limited, GSK Plc, Apnea Sciences Corporation, ZQuiet (Sleeping Well, LLC), Airway Management, Inc., Fisher & Paykel Healthcare Limited, and Tomed GmbH.

The Europe Anti-snoring Device Market is on a strong and sustainable growth path, driven by rising awareness of sleep health, demographic shifts, and continuous technological innovation. With the market projected to grow to US$919.37 million by 2033 at a CAGR of 7.36%, anti-snoring devices are steadily moving from niche wellness products to mainstream healthcare solutions.

While challenges such as uneven regional awareness and patient compliance persist, the overall trajectory remains highly positive. As sleep health becomes a central pillar of preventive medicine and personal well-being in Europe, demand for effective, comfortable, and accessible anti-snoring solutions is set to accelerate. For manufacturers, healthcare providers, and investors alike, this market represents a compelling intersection of medical need, technological progress, and long-term growth potential.